Is FONAR Corp. overvalued or undervalued?

As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value.
In comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, while Longboard Pharmaceuticals, Inc. shows a significantly negative P/E of -27.0419, indicating that FONAR is in a better position relative to this peer. The return performance of FONAR Corp. has lagged behind the S&P 500, with a 1Y return of -1.08% compared to the S&P 500's 14.08%, reflecting challenges in the stock's performance over the past year.